Hsbc Holdings PLC Has $23.01 Million Stake in DaVita Inc. $DVA

Key Points

• HSBC Holdings PLC has reduced its stake in DaVita Inc. by 1.9%, now holding 150,918 shares valued at approximately $23 million.
• Other institutional investors, like UMB Bank and National Pension Service, have increased their stakes in DaVita significantly, indicating a strong interest in the company.
• DaVita's quarterly earnings exceeded estimates with an EPS of $2.95, while the stock's price target has seen adjustments from major analysts, suggesting varied market perspectives.

Hsbc Holdings PLC trimmed its stake in shares of DaVita Inc. (NYSE:DVA - Free Report) by 1.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 150,918 shares of the company's stock after selling 2,920 shares during the period. Hsbc Holdings PLC owned about 0.20% of DaVita worth $23,012,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of DVA. Raymond James Financial Inc. purchased a new stake in shares of DaVita during the fourth quarter valued at $3,864,000. Mariner LLC lifted its holdings in shares of DaVita by 3.8% during the fourth quarter. Mariner LLC now owns 6,438 shares of the company's stock valued at $963,000 after purchasing an additional 233 shares during the last quarter. Marshall Wace LLP purchased a new stake in shares of DaVita during the fourth quarter valued at $1,987,000. GeoWealth Management LLC lifted its holdings in shares of DaVita by 30.6% during the fourth quarter. GeoWealth Management LLC now owns 525 shares of the company's stock valued at $79,000 after purchasing an additional 123 shares during the last quarter. Finally, TD Waterhouse Canada Inc. lifted its holdings in shares of DaVita by 179.5% during the fourth quarter. TD Waterhouse Canada Inc. now owns 981 shares of the company's stock valued at $147,000 after purchasing an additional 630 shares during the last quarter. 90.12% of the stock is owned by hedge funds and other institutional investors.

DaVita Stock Down 1.3%

Shares of DVA traded down $1.82 during midday trading on Thursday, reaching $135.74. 465,798 shares of the stock were exchanged, compared to its average volume of 854,948. DaVita Inc. has a 12-month low of $126.07 and a 12-month high of $179.60. The firm has a 50 day simple moving average of $139.70 and a 200-day simple moving average of $143.37. The company has a quick ratio of 1.34, a current ratio of 1.39 and a debt-to-equity ratio of 23.18. The company has a market cap of $9.71 billion, a price-to-earnings ratio of 13.35, a P/E/G ratio of 0.99 and a beta of 1.09.

DaVita (NYSE:DVA - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, topping analysts' consensus estimates of $2.70 by $0.25. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company had revenue of $3.38 billion during the quarter, compared to the consensus estimate of $3.36 billion. During the same period last year, the business earned $2.00 EPS. The business's quarterly revenue was up 6.1% on a year-over-year basis. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. Research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Ratings Changes

Several brokerages have recently commented on DVA. Truist Financial set a $148.00 target price on DaVita in a report on Friday, August 8th. Barclays reduced their price objective on DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Finally, Wall Street Zen raised DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $164.00.

Insider Buying and Selling at DaVita

In other news, insider James O. Hearty sold 2,351 shares of the firm's stock in a transaction dated Wednesday, July 23rd. The stock was sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the sale, the insider directly owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.50% of the stock is owned by company insiders.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.